George, ., Wang, ., & Pang, . (n.d.). Endpoints for cancer clinical trials. In . George (Ed.), Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis (pp. 3–36). Chapman & Hall/CRC.

George, Herbert, Herbert Wang, and Herbert Pang. “Endpoints for cancer clinical trials.” In Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by Herbert George, 3–36. Chapman & Hall/CRC, n.d.

George, Wang, Pang. Endpoints for cancer clinical trials. In: George, editor. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall/CRC; p. 3–36.

George, Herbert, et al. “Endpoints for cancer clinical trials.” Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by Herbert George, Chapman & Hall/CRC, pp. 3–36.

George, Wang, Pang. Endpoints for cancer clinical trials. In: George, editor. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall/CRC; p. 3–36.